Bio-Techne Corp
NASDAQ:TECH
Bio-Techne Corp
NASDAQ:TECH
Price:
76.06 USD
-1.59%
Market Closed
Updated:
May 7, 2024
Bio-Techne Corp
Cash from Operating Activities
|
Bio-Techne Corp
Cash from Operating Activities Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bio-Techne Corp
NASDAQ:TECH
|
Cash from Operating Activities
$276.4m
|
CAGR 3-Years
3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Operating Activities
$8.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
|
Danaher Corp
NYSE:DHR
|
Cash from Operating Activities
$7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Operating Activities
$965.9m
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Operating Activities
$2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
19%
|
See Also
What is Bio-Techne Corp's Cash from Operating Activities?
Cash from Operating Activities
276.4m
USD
276.4m
USD
Based on the financial report for Dec 31, 2023, Bio-Techne Corp's Cash from Operating Activities amounts to 276.4m USD.
What is Bio-Techne Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
8%
8%
Over the last year, the Cash from Operating Activities growth was -7%. The average annual Cash from Operating Activities growth rates for Bio-Techne Corp have been 3% over the past three years , 10% over the past five years , and 8% over the past ten years .
You don't have any saved screeners yet
